A Phase 1/2 Study of M3814 (peposertib) in Combination with Hypofractionated Radiotherapy for the Treatment of Locally Advanced Pancreatic Adenocarcinoma

Brief description of study

A Phase 1/2 Study of M3814 (peposertib) in Combination with Hypofractionated Radiotherapy for the Treatment of Locally Advanced Pancreatic Adenocarcinoma


Clinical Study Identifier: s21-00991
ClinicalTrials.gov Identifier: NCT04172532


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.